GLOBUS MEDICAL, INC. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
GLOBUS MEDICAL, INC. (GMED) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $63.88 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-02-24
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $5.25M, a 51.92% decline year-over-year.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-03-31 was $58.63M, a 68876.47% increase year-over-year.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $63.88M, a 8.89% increase from fiscal 2024.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $58.67M, a 75.58% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $240.19M, a 23.07% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $312.22M, a 36.99% increase from fiscal 2021.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month as first filed | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.25M derived: sum of 2 quarters · filed 2026-02-24 | $5.25M derived: sum of 3 quarters · filed 2026-02-24 | $63.88M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $58.63M 10-Q · filed 2025-11-06 | $69.55M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $58.63M 10-Q · filed 2025-08-07 | $69.55M derived: sum of 3 quarters · filed 2026-02-24 | $95.59M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2025-03-31 | $58.63M 10-Q · filed 2025-05-08 | $69.55M derived: sum of 2 quarters · filed 2026-02-24 | $95.59M derived: sum of 3 quarters · filed 2026-02-24 | $117.21M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-12-31 | $10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $36.96M derived: sum of 2 quarters · filed 2026-02-24 | $58.58M derived: sum of 3 quarters · filed 2026-02-24 | $58.67M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $26.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $47.66M derived: sum of 2 quarters · filed 2025-11-06 | $47.75M 10-Q · filed 2025-11-06 | $73.51M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-06-30 | $21.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $21.71M 10-Q · filed 2025-08-07 | $47.47M derived: sum of 3 quarters · filed 2026-02-24 | $102.57M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2024-03-31 | $85.00K 10-Q · filed 2025-05-08 | $25.84M derived: sum of 2 quarters · filed 2026-02-24 | $80.95M derived: sum of 3 quarters · filed 2026-02-24 | $154.73M derived: sum of 4 quarters · filed 2026-02-24 | |||
| 2023-12-31 | $25.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $80.86M derived: sum of 2 quarters · filed 2026-02-24 | $154.64M derived: sum of 3 quarters · filed 2026-02-24 | $240.19M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $55.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $128.88M derived: sum of 2 quarters · filed 2024-11-05 | $214.43M 10-Q · filed 2024-11-05 | $287.52M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $73.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $159.33M 10-Q · filed 2024-08-06 | $232.42M derived: sum of 3 quarters · filed 2025-02-20 | $300.98M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | $85.55M 10-Q · filed 2024-05-07 | $158.64M derived: sum of 2 quarters · filed 2025-02-20 | $227.19M derived: sum of 3 quarters · filed 2025-02-20 | $291.22M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | $73.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $141.65M derived: sum of 2 quarters · filed 2025-02-20 | $205.67M derived: sum of 3 quarters · filed 2025-02-20 | $312.22M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $68.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $132.58M derived: sum of 2 quarters · filed 2023-11-07 | $239.13M 10-Q · filed 2023-11-07 | $295.15M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $64.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $170.57M 10-Q · filed 2023-08-03 | $226.59M derived: sum of 3 quarters · filed 2024-02-21 | $266.74M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $106.55M 10-Q · filed 2023-05-04 | $162.57M derived: sum of 2 quarters · filed 2024-02-21 | $202.72M derived: sum of 3 quarters · filed 2024-02-21 | $294.61M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $56.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $96.17M derived: sum of 2 quarters · filed 2024-02-21 | $188.06M derived: sum of 3 quarters · filed 2024-02-21 | $227.91M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $40.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $132.04M derived: sum of 2 quarters · filed 2022-11-08 | $171.89M 10-Q · filed 2022-11-08 | $205.52M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | $91.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $131.74M 10-Q · filed 2022-08-04 | $165.37M derived: sum of 3 quarters · filed 2023-02-21 | $177.82M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-03-31 | $39.85M 10-Q · filed 2022-05-10 | $73.48M derived: sum of 2 quarters · filed 2023-02-21 | $85.93M derived: sum of 3 quarters · filed 2023-02-21 | $102.55M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | $33.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $46.08M derived: sum of 2 quarters · filed 2023-02-21 | $62.70M derived: sum of 3 quarters · filed 2023-02-21 | $134.46M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $12.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $29.06M derived: sum of 2 quarters · filed 2021-11-04 | $100.83M 10-Q · filed 2021-11-04 | $142.02M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-06-30 | $16.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $88.38M 10-Q · filed 2021-08-04 | $129.57M derived: sum of 3 quarters · filed 2022-02-17 | $173.82M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2020-03-31 | $71.77M 10-Q · filed 2021-05-04 | $112.96M derived: sum of 2 quarters · filed 2022-02-17 | $157.21M derived: sum of 3 quarters · filed 2022-02-17 | $228.32M derived: sum of 4 quarters · filed 2022-02-17 | |||
| 2019-12-31 | $41.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $85.44M derived: sum of 2 quarters · filed 2022-02-17 | $156.55M derived: sum of 3 quarters · filed 2022-02-17 | $247.01M 10-K · filed 2022-02-17 | |||
| 2019-09-30 | $44.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | $115.36M derived: sum of 2 quarters · filed 2020-10-28 | $205.82M 10-Q · filed 2020-10-28 | $205.82M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-06-30 | $71.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $161.57M 10-Q · filed 2020-08-05 | $161.57M derived: sum of 3 quarters · filed 2021-02-17 | $281.51M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2019-03-31 | $90.45M 10-Q · filed 2020-05-07 | $90.45M derived: sum of 2 quarters · filed 2021-02-17 | $210.40M derived: sum of 3 quarters · filed 2021-02-17 | $295.17M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17 | $119.95M derived: sum of 2 quarters · filed 2021-02-17 | $204.72M derived: sum of 3 quarters · filed 2021-02-17 | $278.05M 10-K · filed 2021-02-17 | |||
| 2018-09-30 | $119.95M derived: 10-K 9 month − 10-Q 6 month · filed 2020-02-20 | $204.72M derived: sum of 2 quarters · filed 2020-02-20 | $278.05M 10-K · filed 2020-02-20 | $210.07M 10-Q · filed 2018-11-08 | $349.98M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $84.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $158.10M 10-Q · filed 2019-08-01 | $230.04M derived: sum of 3 quarters · filed 2020-03-02 | $295.06M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $73.33M 10-Q · filed 2019-05-02 | $145.26M derived: sum of 2 quarters · filed 2020-03-02 | $210.28M derived: sum of 3 quarters · filed 2020-03-02 | $258.28M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $71.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $136.96M derived: sum of 2 quarters · filed 2020-03-02 | $184.95M derived: sum of 3 quarters · filed 2020-03-02 | $240.35M 10-K/A · filed 2020-03-02 | |||
| 2017-09-30 | $65.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $113.01M derived: sum of 2 quarters · filed 2018-11-08 | $168.42M 10-Q · filed 2018-11-08 | $166.45M 10-Q · filed 2017-11-09 | $239.16M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-06-30 | $47.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $103.40M 10-Q · filed 2018-08-02 | $102.73M 10-Q · filed 2017-08-03 | $174.15M derived: sum of 3 quarters · filed 2019-02-21 | $255.79M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2017-03-31 | $55.41M 10-Q · filed 2018-05-03 | $55.28M 10-Q · filed 2017-05-04 | $126.15M derived: sum of 2 quarters · filed 2019-02-21 | $207.79M derived: sum of 3 quarters · filed 2019-02-21 | $267.63M derived: sum of 4 quarters · filed 2019-02-21 | ||
| 2016-12-31 | $70.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $152.39M derived: sum of 2 quarters · filed 2019-02-21 | $212.23M derived: sum of 3 quarters · filed 2019-02-21 | $281.88M 10-K · filed 2019-02-21 | |||
| 2016-09-30 | $81.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $141.48M derived: sum of 2 quarters · filed 2017-11-09 | $211.14M 10-Q · filed 2017-11-09 | $268.52M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-06-30 | $59.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $129.50M 10-Q · filed 2017-08-03 | $186.88M derived: sum of 3 quarters · filed 2018-02-22 | $232.75M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-03-31 | $69.66M 10-Q · filed 2017-05-04 | $127.04M derived: sum of 2 quarters · filed 2018-02-22 | $172.91M derived: sum of 3 quarters · filed 2018-02-22 | $193.78M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $57.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $103.26M derived: sum of 2 quarters · filed 2018-02-22 | $124.13M derived: sum of 3 quarters · filed 2018-02-22 | $188.70M 10-K · filed 2018-02-22 | |||
| 2015-09-30 | $45.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $66.74M derived: sum of 2 quarters · filed 2016-11-09 | $131.32M 10-Q · filed 2016-11-09 | $171.68M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $20.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $85.44M 10-Q · filed 2016-07-27 | $125.80M derived: sum of 3 quarters · filed 2017-03-16 | $174.72M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $64.57M 10-Q · filed 2016-05-04 | $104.93M derived: sum of 2 quarters · filed 2017-03-16 | $153.85M derived: sum of 3 quarters · filed 2017-03-16 | $202.89M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $40.36M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $89.28M derived: sum of 2 quarters · filed 2017-03-16 | $138.32M derived: sum of 3 quarters · filed 2017-03-16 | $184.57M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $48.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $97.96M derived: sum of 2 quarters · filed 2015-11-04 | $144.21M 10-Q · filed 2015-11-04 | $165.77M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $49.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $95.29M 10-Q · filed 2015-07-31 | $116.85M derived: sum of 3 quarters · filed 2016-02-29 | $131.95M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $46.25M 10-Q · filed 2015-05-05 | $67.81M derived: sum of 2 quarters · filed 2016-02-29 | $82.91M derived: sum of 3 quarters · filed 2016-02-29 | $86.81M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $21.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $36.66M derived: sum of 2 quarters · filed 2016-02-29 | $40.56M derived: sum of 3 quarters · filed 2016-02-29 | $40.56M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $19.00M derived: sum of 2 quarters · filed 2014-10-31 | $19.00M 10-Q · filed 2014-10-31 | $19.00M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $3.90M 10-Q · filed 2014-08-06 | $3.90M derived: sum of 3 quarters · filed 2015-02-26 | $3.90M derived: sum of 4 quarters · filed 2015-02-26 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-30 | $0.00 derived: sum of 2 quarters · filed 2015-02-26 | $0.00 derived: sum of 3 quarters · filed 2015-02-26 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $0.00 derived: sum of 2 quarters · filed 2015-02-26 | $0.00 10-K · filed 2015-02-26 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $0.00 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-02 | ||||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |